Indicatum

Investera med insikt - Data visar vägen!

Bevaka (0)

Orexo

Lista

Small Cap

Sektor

Health Care

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.


Ranks


Kursgraf

Länk till dynamisk (zoombar) graf för större skärmar


Nuvarande och kommande formation


MA Rank

Free stock photo of 4k wallpaper, bridge, daylight
Photo by Markus Spiske on Pexels

Välkommen till Indicatum!

Vi bygger vår nya plattform och kan tyvärr inte ta emot nyregistreringar just nu, men registrera din e-postadress nedan så får du en notis när vi lanserar tjänsten.

Vi ser fram emot att höra från dig!

Vi spammar inte!
Din email kommer endast att användas för att meddela dig när plattformen lanseras

Rulla till toppen